TABLE 1.
Viral phenotypea | No. of isolates | % of replicating isolates using:
|
|||||
---|---|---|---|---|---|---|---|
FC-1
|
FC-2
|
FC-4b
|
|||||
p24 onlyb | p24 + syncc | p24 only | p24 + sync | p24 only | p24 + sync | ||
R5 nonswitch | 64 | 20 | 2 | 3 | 63 | 22 | 17d |
R5 switch | 109 | 37 | 8 | 6 | 79 | 17 | 63 |
CXCR4 using | 73 | 14 | 51 | 7 | 89 | 0 | 100 |
R5 nonswitch, R5 isolates from patients with CCR5-using virus throughout the study; R5 switch, R5 isolates preceding the acquisition of CXCR4-using virus in patients with a detected switch to X4, R5X4, or multitropic virus; CXCR4 using, X4, R5X4, or multitropic isolates from the patients in the R5 virus switch group.
p24 only, p24 antigen production but no syncytium formation.
p24 + sync, syncytium induction and p24 antigen production.
Significantly lower numbers and percentages of replicating R5 isolates were obtained from nonswitch virus patients than from R5 switch virus patients when two isolates from each patient were analyzed as described for Table 2 (P = 0.01, chi-square analysis).